Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_assertion type Assertion NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_head.
- NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_assertion description "[However, these two pathways are not redundant, as indicated by differential effects observed in cell cycle regulation following siRNA-mediated inhibition of Cdk9 and/or Cdk7 in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_provenance.
- NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_assertion evidence source_evidence_literature NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_provenance.
- NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_assertion SIO_000772 22391209 NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_provenance.
- NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_assertion wasDerivedFrom befree-20150227 NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_provenance.
- NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_assertion wasGeneratedBy ECO_0000203 NP302059.RAzMFJbSo_eaRRN1pm5qFW5OqZlXJBW2cAw_fe2wfPG14130_provenance.